NEU:ASX
Neuren Pharmaceuticals Ltd
A$12.95
arrow_downward
-3.29%(-0.44) 1D
Jun 15, 4:10:23 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$13.41
High
A$13.62
Low
A$12.95
Mkt. cap
1.64B
Avg. vol.
320.14K
Volume
294.82K
P/E ratio
55.64
52-wk high
A$22.98
52-wk low
A$11.00
EPS
A$0.23
Shares outstanding
126.32M
No. of employees
8
Open
A$13.41
High
A$13.62
Low
A$12.95
Mkt. cap
1.64B
Avg. vol.
320.14K
Volume
294.82K
P/E ratio
55.64
52-wk high
A$22.98
52-wk low
A$11.00
EPS
A$0.23
Shares outstanding
126.32M
No. of employees
8
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NEU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NEU in the last 3 months.
Highest
Current A$12.95
A$24.00 (+85.33%)
Average
A$23.00 (+77.57%)
Lowest
A$22.00 (+69.88%)
News stories
From sources across the web
Nasdaq
·
5 minutes ago
RRE Ventures Acquisition Corp. Rings the Opening Bell
MarketWatch
·
1 hour ago
The stock market is poised to go crazy if Warsh gives it the go-ahead, these strategists say
Stock Titan
·
1 hour ago
NIP Group (NASDAQ: NIPG) plans 1-for-30 ADS ratio change
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com
AI content may include mistakes. Learn more